Whitepaper: Streamlining pharma operations in the wake of COVID-19
This white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment. He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.
Related content from this organisation
- Whitepaper: Streamlining pharma operations in the wake of COVID-19
- On-demand webinar: An update on remote and virtual auditing
- Whitepaper: Effective and fast approval of incident investigation reports
- On-demand webinar: Outsourcing selected areas of the quality system
- Whitepaper: Management of change under pressure and how to communicate with regulators in challenging times